Estimating a frequency of a sampled cardiac rhythm signal and classifying the rhythm. The received signal is sampled and transformed into a curvature series. A lobe in the curvature series corresponds to a characteristic point in the sampled series. Characteristic points are selected based on a time of a lobe in the curvature series and, in one embodiment, an amplitude of the signal at the time of the lobe. A frequency of the sampled series is estimated by autocorrelating a function of the series of the characteristic points. In one embodiment, the function is a time difference function. The rhythm is classified by plotting the timewise proximity of characteristic points derived from an atrial signal with characteristic points derived from a ventricular signal. Regions of the plot are associated with a particular rhythm and the grouping of the data corresponds to the classification.
|
1. An implantable cardiac rhythm management device comprising:
a ventricular channel input circuit to receive a sampled ventricular input signal for an epoch;
an atrial channel input circuit to receive a sampled atrial input signal for the epoch;
a controller coupled to the ventricular channel input circuit and coupled to the atrial channel input circuit, the controller adapted to determine relative timing between ventricular characteristic points and atrial characteristic points, each characteristic point determined based on a curvature series generated as a function of the input signals, each characteristic point having a time of a lobe in the curvature series; and
a discriminator circuit coupled to the controller and adapted to classify the epoch based on a comparison of a first function of the atrial characteristic points and a second function of the ventricular characteristic points,
wherein the controller is adapted to compute a ventricular curvature series using the sampled ventricular input signal for the epoch and an atrial curvature series using the sampled atrial input signals for the epoch, identify lobes using a curvature threshold value in each of the ventricular curvature series and the atrial curvature series, generate the ventricular characteristic points each associated with a lobe of the identified lobes in the ventricular curvature series, and generate the atrial characteristic points each associated with a lobe of the identified lobes in the atrial curvature series, wherein the ventricular curvature series includes curvatures each computed as a non-linear function of first and second derivatives of the sampled ventricular input signal, and the atrial curvature series includes curvatures each computed as a non-linear function of first and second derivatives of the sampled atrial input signal.
2. The device of
3. The device of
4. The device of
5. The device of
6. The device of
8. The device of
9. The device of
10. The device of
11. The device of
12. The device of
13. The device of
14. The device of
15. The device of
16. The device of
|
This application is a divisional of and claims the benefit of priority under 35 U.S.C. §120 to U.S. patent application Ser. No. 10/607,818, filed on Jun. 27, 2003, now issued as U.S. Pat. No. 7,792,571, which is hereby incorporated by reference herein in its entirety.
This document is related to commonly assigned U.S. patent application Ser. No. 09/703,269, entitled “CURVATURE BASED METHOD FOR SELECTING FEATURES FROM AN ELECTROPHYSIOLOGICAL SIGNALS FOR PURPOSE OF COMPLEX IDENTIFICATION AND CLASSIFICATION,” inventor Sweeney et al., filed on Oct. 31, 2000, now issued as U.S. Pat. No. 6,684,100, the specification of which is hereby incorporated by reference in its entirety.
This document is related to commonly assigned U.S. patent application Ser. No. 10/195,838, entitled “USE OF CURVATURE BASED FEATURES FOR BEAT DETECTION,” inventor Sweeney, filed on Jul. 15, 2002, now issued as U.S. Pat. No. 6,950,702, the specification of which is hereby incorporated by reference in its entirety.
This document is related to co-pending and commonly assigned U.S. patent application Ser. No. 10/607,820 entitled “SIGNAL COMPRESSION BASED ON CURVATURE PARAMETERS,” inventor Sweeney, filed on Jun. 27, 2003, now issued as U.S. Pat. No. 7,500,955, the specification of which is hereby incorporated by reference in its entirety.
This document relates generally to cardiac rhythm management and in particular, but not by way of limitation, to detection and discrimination of arrhythmias in an implantable medical device.
Implantable cardiac rhythm management devices typically monitor and process cardiac signals to provide therapy to the heart. Therapy may include delivering a pacing pulse to trigger a contraction of the heart or delivering a defibrillation shock to interrupt an abnormal heart rhythm. Some cardiac rhythm management devices also monitor cardiac performance or other physiological parameters for use in controlling the delivery of pacing pulses.
Before delivering therapy, some implantable cardiac rhythm management devices are programmed to verify that an arrhythmia is occurring. In addition, therapy can be tailored to the patient's needs if the rhythm type is known.
There exists an unmet need for providing improved arrhythmia detection and discrimination systems, devices, and methods to allow better diagnosis or treatment of patients.
The present subject matter provides a curvature based method of selecting features from a sampled signal. In one embodiment, the sampled signal includes a cardiac signal or an electrocardiogram. According to one aspect of the present subject matter, characteristic points are selected by sensing a cardiac signal on a real-time basis and upon receipt of each sample, computing curvatures on a continuous basis. Characteristic points are sometimes referred to as significant points or data points.
In one embodiment, each “turn” in the signal is represented with a characteristic point that has measures of time, value, area and width. Time refers to a time denoting the center of the turn in the curvature series. Value refers to the amplitude of the input signal at the time of the center of the turn. Area refers to a value denoting the direction and degree of the turn. Width refers to a value denoting the duration over which the turn occurs.
By the methods presented herein, each new characteristic point is known as soon as the turn which it describes has ended. In one embodiment, the stream of characteristic points are analyzed continuously as each new characteristic point occurs. In one embodiment, the characteristic points are saved into a buffer for analysis at a later time.
All turns in an input signal are not the same. Some turns may be large deflections with sharp angles (for example, turns in a QRS signal) while other turns might be slight and not associated with big deflections (for example, noise in the signal). In one embodiment, the present subject matter includes a scheme to select prominent characteristic points in a signal and discard the smaller ones that may represent noise or only slight signal deflections.
The area for the characteristic point is an indirect measure of the angular turn in the signal. The maximum turn is approximately 180 degrees which represents a very rapid signal reversal. A large deflection in the signal, such as the R-wave (a full signal swing in 10 samples over, a period of 50 ms) would have large turn angle of 178 degrees. A small noise spike (such as a 10% full scale swing for a single sample) may also have a large turn angle of 175 degrees. The present subject matter treats these signal deflections differently. The R-wave has a large area whereas the noise spike would have a small area since it occurred over a lower number of samples. Thus, the characteristic point area is a surrogate for determining which characteristic points are important and which are not.
The effect of the foregoing is that small characteristic points at or near the signal baseline value are ignored. According to one embodiment, an absolute area threshold value in the range of 0.5 is used for a rate-sensing channel.
In one embodiment, the present subject matter automatically adjusts the threshold value to better adapt to varying patients and signals.
In one embodiment, each characteristic point includes a time component, an amplitude component and an area component. According to the present subject matter, the time, amplitude and area components are derived from a curvature calculation performed using the sampled signal.
Typical cardiac rhythm management devices determine the heart rate by sensing beats in a cardiac electrical signal and detecting when an R wave occurs in the signal. An R wave (sometimes referred to as a QRS complex) represents the major electrical event for each beat of the heart. In one embodiment, the plurality of characteristic points are analyzed to determine a heart rate without relying on beat sensing. In one embodiment, a first estimate of heart rate is generated by autocorrelating a particular function of characteristic points. In one embodiment, a time difference autocorrelation function yields the heart rate. In one embodiment, a second estimate of the heart rate (or beat frequency) is generated by a secondary process and the two estimates are reconciled to derive a single value for the heart rate.
In one embodiment, an atrial series of characteristic points are generated for an atrial channel and a ventricular series of characteristic points are generated for a ventricular channel. The relative timing of the atrial series and the ventricular series are compared and the comparison forms the basis for discriminating among different rhythm types. Other methods are also contemplated including discriminating on the basis of variations in characteristic point timing and cross-correlations in the characteristic point domain.
In one embodiment, a window is established before each ventricular characteristic point. Relative timing is evaluated by counting atrial and ventricular characteristic points relative to the windows and graphically plotting the results on a grid. The grid is divided into regions corresponding to different rhythm types.
Other aspects of the invention will be apparent on reading the following detailed description of the invention and viewing the drawings that form a part thereof.
In the drawings, like numerals describe substantially similar components throughout the several views. Like numerals having different letter suffixes represent different instances of substantially similar components.
In the following detailed description, reference is made to the accompanying drawings that form a part hereof, and in which is shown, by way of illustration, specific embodiments in which the invention may be practiced. These embodiments are described in sufficient detail to enable those skilled in the art to practice the invention, and it is to be understood that the embodiments may be combined, or that other embodiments may be utilized and that structural, logical and electrical changes may be made without departing from the scope of the present subject matter. The following detailed description is, therefore, not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims and their equivalents.
This document discloses, among other things, systems, method and apparatus involving cardiac rhythm management systems used for sensing a cardiac signal, including intracardiac electrogram or surface electrocardiogram (ECG). Such cardiac rhythm management systems include, but are not limited to, pacemakers, CRT devices, cardioverter/defibrillators, pacer/defibrillators, and drug delivery devices. However, it is to be understood that the present methods and apparatuses of compressing a signal can be applied to heart beat detection as well as other signals related to cardiac activities, including, but not being limited to, mechanical motion, sound, pressure, acceleration, and impedance signals.
Curvature Based Analysis
For an arbitrary voltage versus time signal, the salient characteristics can be captured in terms of those points along the signal where it makes characteristic “turns.” In general, these points are different from those that would be selected using first or second derivative criteria as shown in
On the other hand, points 102, 103, 104 and 105 are neither maximums nor minimums of the electrogram or its derivatives. These points are descriptive of the arbitrary waveform shape. Points 102, 103, 104 and 105 are salient because they mark locations where the signal makes significant turns. The turn at point 101 is very sharp and the turns at points 103 and 105 are less sharp turns and more broad. The turns at points 102 and 104 are even less sharp but rather local. The present subject matter detects points 101, 102, 103, 104 and 105 using a criteria based on the curvature of the signal.
According to one embodiment of the present subject matter, signal curvature is illustrated in
In general, the curvature at point (X, Y) of an arbitrary curve in a two-dimensional space is expressed as:
As seen, the curvature is a non-linear combination of both the first and second derivatives of the curve. At those points along the curve where the first derivative is zero (for example, point 101 in
The present subject matter calculates curvature of an arbitrary input signal on a sample-by-sample basis.
Consider the question of dimensionality of the curvature for electrogram signals. When both X and Y have the same dimensions (say length) then curvature has a dimension of 1/length. For an arbitrary signal having a voltage as a function of time V(t), such as an electrocardiogram, the signal is transformed into a time-versus-time signal T(t) according to T(t)=V(t)/U where U is a constant with dimensions of voltage/time. With this transformation, the first and second derivatives of T(t) become
and thus the curvature has dimensions of 1/time. Curvature is then expressed as:
which has dimensions of 1/time and U has a numerical value.
Consider next, curvature as a function of signal gain or amplitude of the input signal. Assume arbitrary gain G is applied to the input signal to find a new input signal F(t) wherein F(t)=G·T(t)=V(t)·G/U. The curvature of the gained signal is then:
The ratio G/U can be expressed as W having dimensions of time/voltage. In one embodiment, the input signal is a voltage sampled with a 12-bit analog-to-digital converter (ADC) having numerical voltage values in the range +/−2048 where each value represents a number of basic amplitude units ΔV, or voltage resolution. In one embodiment, the amplifiers in the present subject matter are adjusted so that the samples from V(t) largely fill this range. Furthermore, it is assumed that the samples are taken at a fixed rate and thus the time is represented by an integer number of samples with each sample representing a time interval ΔT=time resolution=1/(sample rate).
In one embodiment, W is selected to require that a square in voltage-time space be represented by a square in sample-sample space. Under that condition, the curvature versus time relationships that exist in voltage-time space are preserved in sample-sample space.
In
To maintain this relationship between voltage-time and sample-sample space, W is selected as follows. In voltage-time space, the box T wide by V high is taken to be square. In sample-sample space, the box is T/ΔT time-samples wide and GV/ΔV voltage-samples high and through a transformation, the voltage sample is converted into time-samples using U so that the sample-space square has dimensions of T/ΔT by VG/ΔV/U. For the box to be square in sample-space, and assuming the box (V by T) in voltage-time space is square, then (V/ΔV)·G/U=T/ΔT or G/U=W=(T/ΔT)/(V/ΔV).
According to one embodiment of the present subject matter, curvature is based on the first and second derivative of the signal. A least square cubic polynomial fit is used to reduce the noise that would otherwise result from using numerical estimates for the derivatives and using non-linear calculations to find curvature.
The sampled voltage signal is expressed as V(t)=V(I·ΔT) where t=i·ΔT so that the fit of size N uses 2N+1 voltage samples centered on the time t, thus:
V([i−n]·ΔT), . . . V([i−2]·ΔT),V([i−1]·ΔT),V(i·ΔT),V([i+1]·ΔT),V([i+2]·ΔT), . . . V([i+n]·ΔT).
This set of N sampled data points is used to make the least-squares cubic fit which is given as Vest[i·ΔT+dt]=Ai+Bi·[dt]+Ci·[dt]2+Di·[dt]3 where Ai, Bi, Ci, and Di are coefficients determined by minimizing the square error for the fit and dt represents a time step away from i·ΔT at which Vest is evaluated. The coefficients in the polynomial are denoted with an i to indicate that they are valid for the point i·ΔT.
Using the above equations, the curvature on a point to point basis, at the time i·ΔT, becomes
Sample points, however, will not necessarily fall at the times where the signal curvature has a maximum or minimum value. Thus, in one embodiment, the curvature signal is integrated between adjacent sample points using estimates for the first and second derivative of the signal at the sample points.
Further simplification yields an expression for average point curvature as:
As noted, curvature is computed on a sample-by-sample basis from the input signal.
Consider next, a procedure for finding the characteristic points in the signal.
Turns in the original signal are reflected as excursions above and below zero in the curvature signal. As suggested by curvature 160 of
A point-by-point method is used to identify the lobes as they occur and to find the area and centroid of each lobe.
Curvature values are generated on a sample by sample basis. At each sample time, CRV represents the current curvature value and CRVold represents the previous value that is retained from the previous sample. When the curvature value is zero, the original signal is not turning so that no characteristic points may exist. The value CRV will rarely be exactly equal to zero.
In one embodiment, a dead-zone surrounding zero is defined where the calculated curvature may be treated as equal to zero. For times where the curvature is within the zone, the signal is not turning significantly. The zone is defined with a curvature threshold value and extends above and below zero from +CRVthresh to −CRVthresh.
In one embodiment, the present subject matter identifies nine cases for considering the value of CRV relative to the threshold and the absence or direction of a lobe. These cases can be described as follows:
Case 1: CRV>CRVthresh and not in a lobe.
Here, the current curvature value is above the dead-zone and the curvature signal is not currently in a lobe. Thus, a positive lobe has just started so the positive lobe initialization calculations will follow.
Case 2: CRVthresh≧CRV≧−CRVthresh and not in a lobe.
Here, the current curvature values is inside the dead-zone and the curvature signal is not currently in a lobe.
Case 3: CRV<−CRVthresh and not in a lobe.
Here, the current curvature value is below the dead-zone and the curvature signal is not currently in a lobe. Thus, a negative lobe has just started so the negative lobe initialization calculations will follow.
Case 4: CRV>CRVthresh and in a positive lobe.
Here, the current curvature value is above the dead-zone and the curvature signal is in a positive lobe. Thus, the positive lobe continuation calculations will follow.
Case 5: CRVthresh≧CRV≧−CRVthresh and in a positive lobe.
Here, the current curvature value is inside the dead-zone and the curvature signal is in a positive lobe. Thus, a positive lobe has just ended so the positive lobe finalization calculations will follow.
Case 6: CRV<−CRVthresh and in a positive lobe.
Here, the current curvature value is below the dead-zone and the curvature signal is currently in a positive lobe. Thus, a positive lobe has just ended and a negative lobe has just started so that both the positive lobe finalization calculations and the negative lobe initialization calculations will follow.
Case 7: CRV>CRVthresh and in a negative lobe.
Here, the current curvature value is above the dead-zone and the curvature signal is in a negative lobe. Thus, a negative lobe has just ended and a positive lobe has just started so that both the negative lobe finalization calculations and the positive lobe initialization calculations will follow.
Case 8: CRVthresh≧CRV≧−CRVthresh and in a negative lobe.
Here, the current curvature value is inside the dead-zone and the curvature signal is in a negative lobe. Thus, a lobe has just ended so the negative lobe finalization calculations will follow.
Case 9: CRV<−CRVthresh and in a negative lobe.
Here, the current curvature value is below the dead-zone and the curvature signal is in a negative lobe. Thus, the negative lobe continuation calculations will follow.
In one embodiment, hysteresis is used to aid in identifying curvature lobes. After having started a lobe, one embodiment provides that the curvature value cross a threshold value closer to zero in order for the lobe to finish. Thus, hysteresis introduces another threshold value.
Consider next the metrics for characterizing each lobe according to the present subject matter. In one embodiment, those metrics include the total area of the lobe, the time of the lobe area centroid and the value of the original data at the time of the area centroid. In one embodiment, other metrics are used, including, for example, the peak curvature in the lobe, the time of the peak curvature, and the times of the lobe start and lobe finish.
As shown in the figure, initial curvature values at curvature points 200 and 205 are within the dead-zone of the threshold curvature values and thus, no lobe is yet established. Curvature point 210 is above the threshold and corresponds to Case 1 described above. The magnitude of initial area 250 is calculated as soon as the lobe is started according to case 1 described above. Upon determining curvature point 215, a contribution to the magnitude of main area 255 is calculated according to case 4 described above. In addition, the magnitude of main area 255 is increased with the determination of curvature points 220, 225, and 230. Upon determining curvature point 235 lying below +CRVthresh 190, the magnitude of final area 260 is calculated for the region below curvature lobe 185 and between curvature point 230 and the intersection with +CRVthresh 190. Curvature points 235, 240 and 245 lie in the dead-zone and do not contribute to an area calculation. The area of curvature lobe 185 is calculated to include the sum of initial area 250, main area 255 and final area 260.
In one embodiment, a value M of a counter is maintained by a processor to monitor sample-by-sample development of a lobe. When the ‘start lobe’ calculations are performed, the value for M is reset to zero and incremented with each subsequent point that remains outside the dead-zone. Values for M are illustrated at the different curvature points in
To find the area under the curvature lobe, the value of M is set to zero and the initial area of a curvature lobe is computed as initial area=(Ci+CRVthresh)·(Ci−CRVthresh) when the lobe is started. For each successive curvature value, the value of M is incremented and the additional area contribution is computed as additional area=−(M−1)·Ci+M·Ci−1. When the lobe ends, the value of M is not incremented and the final area contribution is computed as final area=M·Ci−1+(Ci+CRVthresh)·(Ci−CRVthresh)/(Ci−Ci−1). The sum of the initial, final, and all additional areas may then be multiplied by ΔT/2 to find the area under the curvature lobe.
To find the first moment of the area under the curvature lobe, a similar approach is used. When the initial area of the curvature lobe is computed, the initial moment of the area is also computed as initial moment=−{C1+2CRVthresh} ·γ2 where γ=(CRVthresh−Ci−1)/(Ci−Ci−1). For each successive curvature value in the lobe, an additional moment contribution is computed using the same M values as for the area computations. This additional moment contribution is computed as additional moment={Ci·(3M−1)+Ci−1·(3M−2)}. When the lobe ends, a final moment contribution is computed at the same time that the final area is computed. The final moment is computed as final moment=[CRVthresh·{3M+2γ}+Ci−1·{3M+γ}]·γ.
The sum of the initial, final, and all additional moments may then be multiplied by ΔT2/6 to find the first moment of the area under the curvature lobe. The time of the centroid of the curvature lobe area is found by dividing the first moment of the curvature lobe area by the curvature lobe area as time=first moment of area/area. This time is with respect to the time of the curvature point that started the lobe.
For both the area and the first moment of the area, the calculations are constructed in such a way that the contribution of each curvature sample may be summed into a total area or total first moment of the area as the samples are collected. Thus, for all calculations, the factors include the present and previous curvature values, the threshold values, and the counter M. In this manner the area and the time of the centroid of the area are generated as soon as the lobe is ended.
In one embodiment, the present subject matter identifies characteristic points generated from point-by point processing of an input signal. In one embodiment, the characteristic points in the signal are detected and saved into a buffer. In one embodiment, each characteristic point is a set of values including the time of the characteristic point, the value of the input signal at that time, and a value describing the direction and extent of curve in the signal that produced the characteristic point.
Consider next a method of extracting characteristic points. In one embodiment, characteristic points of an electrocardiogram are extracted using a sampling at 400 Hz. In one embodiment, sampling is performed at 200 Hz. The sampled data is filtered using a 5-point (400 Hz) or 3-point (200 Hz) running average filter and a five least squares regression average-point curvature method to select characteristic points relating to the QRS complex.
For detecting curvatures associated with slower morphologies, sampling is at a slower rate, such as, for example, 50 Hz. An example of a wave having slower morphologies would be the T-wave in an electrocardiogram.
In one embodiment, multiple sampling rates are used for characteristic point extraction.
In one embodiment, dual-rate sampling is performed with sampling at 200 Hz providing fast characteristic points and sampling at 50 Hz providing slow characteristic points and a 3-point running average filter is used. Consider an example of dual-rate sampling using 200 Hz, yielding fast characteristic points, and 50 Hz, yielding slow characteristic points, with 5-point least squares regression size and 3-point running average filtering at both rates.
In one embodiment, curvature is found by using 5-point least squares regression filtering. The coefficients for finding the linear (Bi) and parabolic (Ci) fit coefficients in the cubic least squares regression to the data (Di−2 to Di+2) at the point i are as follows:
Linear
Parabolic
P−2 = (1/12) * Rate
Q−2 = (10/70) * Rate2
P−1 = (−8/12) * Rate
Q−1 = (−5/70) * Rate2
P0 = 0
Q0 = (−10/70) * Rate2
P1 = (8/12) * Rate
Q1 = (−5/70) * Rate2
P2 = (−1/12) * Rate
Q2 = (10/70) * Rate2
where Rate is the sampling rate in sample/sec, Bi is the sum of the products of these P least squares regression coefficients multiplied by the 5 corresponding data points centered on i (Di−2 to Di+2) and Ci is the sum using the Q least squares regression coefficients. Curvature is then computed as:
where W is a constant. Since W appears in conjunction with fit coefficients Ci or Bi, the value can be incorporated into the computations as a data signal gain such that D′(i)=W·D(i). Then, the curvature expression becomes
where B′i and C′i are found using the D′ data points rather than the D data points with the least squares regression coefficients.
The expression for curvature may then be rewritten as:
where Gn is an arbitrary value which is incorporated (with 2) into C″. If the curvature thresholds used for detection of characteristic points is adjusted accordingly, it does not matter whether point-by-point curvature or Gn times the point-by-point curvature is calculated. Incorporating the values 2·Gn into C″i can be accomplished by changing the least squares regression coefficients Q−2 through Q2 into new least squares regression coefficients (Q′−2 through Q′2) by multiplication with 2Gn. If Gn is selected as 7/(6 Rate) and the term Fn=Rate/12 is incorporated as additional data signal gain, then the least squares regression coefficients become:
Linear
Parabolic
P″−2 = 1
Q″−2 = 4
P″−1 = −8
Q″−1 = −2
P″0 = 0
Q″0 = −4
P″1 = 8
Q″1 = −2
P″2 = −1
Q″2 = 4
with D″(i)=2·W·Fn·D(i); and with Ci″=Q″−2·D″(i−2)+Q″−1·D″(i−1)+Q″0·D″(i)+Q″+1·D″(i+1)+Q″+2·D″(i+2); and with Bi″=P″−2·D″(i−2)+P″−1·D″(i−1)+P″0·D″(i)+P″−1·D″(i+1)+P″+2·D″(i+2).
Note that the coefficients are all powers of two (either 0, 1, 2, 4 or 8), thus simplifying hardware or firmware implementation of the present subject matter.
When using two sample rates for determining characteristic points, the computed curvatures will be different when computed at different rates. Thus, two threshold levels and parallel sets of computations are used. Also, the running average filtering is different with the fast rate filtering using five consecutive points while the slow rate filtering uses every fourth point spaced over sixteen points.
In one embodiment, the linearity of the least squares regression operation is used. The running average filtering operation are performed at the fit coefficient level (i.e. the Bs and Cs) rather than the data level. In this embodiment, two filtering operations are performed (one for Bs, one for Cs) at each rate.
In one embodiment, the fast and the slow running average filtering operations are performed in parallel.
In one embodiment, the following method is used to select the values for the characteristic points.
Starting at the time of one sample, the sensing hardware and software of the present subject matter begins acquiring the next sample so that the actual sample reflects the nature of the signal between the last sample and the current sample. At the actual time of the sample, the value of the sample may be ascribed to the time half-way between the current sample and the previous sample. Samples at the slow sample rate apply to the signal two fast sample steps earlier than the actual sample time.
In one embodiment, a circular data buffer is used. Data is acquired at the fast sample rate and used to fill a circular data buffer. Once the timing of a fast or slow characteristic point is determined, the data value for that characteristic point is found from the data stored in the circular buffer. Thus, the data buffer is sized so that the requisite data is still available in the buffer. In one embodiment, the buffer is sized to hold about 500 millisecond of data or 256 data points. In one embodiment, the circular buffer is implemented as a memory array with an index pointer. In one embodiment, the index pointer includes a binary counter and the buffer size is a power of two.
In one embodiment, running average filtering (RAF) is performed on the input data. In various embodiments, the filtering is provided by a circular buffer or a shift register set. The values in the circular data buffer reflect the fast running average filtering. In one embodiment, a hybrid approach is used where the fast running average filtering is performed and then the data is placed into a circular buffer.
In one embodiment, running average filtering reduces curvature noise relative to the signal content of fast curvature signals. An electrocardiogram signal typically takes relatively large excursions away from zero curvature at the times of fast turns in the signal. However, when the fast turns are less severe, the curvature signal does not move as far away from zero and curvature noise can prematurely end the curve lobe. The result is that one small curvature lobe is broken into two or more even smaller lobes. Thus, in one embodiment, the curvature noise relative to the signal content is reduced, for fast curvature signals, by running average filtering.
Filtering of the input signal does not achieve the same effect as filtering the actual curvature signals. In one embodiment, 3-point running average filtering is applied to the fast curvature values.
In one embodiment, fast curvature values are computed as average point curvature and 3-point running average filtering of the curvatures so that the fast curvature value computed when the current sample is taken applies to a time in the input signal that is five time steps earlier than the current sample.
In one embodiment, slow curvature values are computed at ¼ the fast sample rate and are computed as average-point curvatures so that when the every fourth fast sample is taken, slow curvature is computed and it applies at a time in the input signal that is four slow (sixteen fast) time steps earlier than the current sample.
In one embodiment, the detection of a curvature lobe and characteristic points entails both fast and slow characteristic point detection performed in parallel. In one embodiment, separate curvature thresholds and curvature area thresholds are used for the fast and slow operations.
In one embodiment, a curvature lobe is ended when the curvature signal crosses the same threshold used to start the lobe but in the opposite direction of the crossing that started the lobe. In one embodiment, a hysteresis is used so that a curvature lobe is ended when the curvature signal crosses a threshold that is smaller (i.e. closer to zero) than the threshold used to start the lobe but in the opposite direction of the crowing that started the lobe. In one embodiment, a curvature lobe is ended when the curvature signal crosses zero as the hysteresis value.
In one embodiment, the value of W is selected according to the following procedure. Select an approximate range for W from the following analysis. At a 200 Hz sampling rate, the QRS takes approximately five samples. The signal at the peak is approximated by 128. If the QRS were to be approximated (in curvature space) as a semicircle arching from zero to the peak then back to zero in five points, then the radius of that semicircle would be 0.01 sec and the peak would have a value of 0.01. Thus, the value of W would be the one that, when multiplied, the peak (128) would have the value of 0.01, i.e. W=0.01/128=0.000078. In one embodiment, W=0.000122= 1/8192 which is a power of two.
Consider selection of curvature threshold values for characteristic point detection. Thresholds, in one embodiment, reduce or eliminate the noise characteristic points and computational burden. This noise is the natural results of the curvature signal hovering around zero (or some other value) when the raw signal does not otherwise have characteristic turnings.
In one embodiment, for a curvature lobe to be detected, the point-wise curvature falls outside of a dead-band formed by the threshold values on either side of zero. Reducing this threshold towards zero increases the number of curvature lobes that are detected and increases the computational burden. In one embodiment, a threshold value is selected by using approximately a 1 minute epoch of the input signal to make a histogram of the fast curvature values computed at each sample time. The threshold value is selected as one which corresponds to 20% of the peak. This value is then used as the threshold for both the fast curvature and slow curvature feature selection process.
In one embodiment, the noise lobes are removed by requiring that a detected lobe must exceed a critical area limit. The noise lobes have generally small areas while the real lobes associated with characteristic turns in the signal usually have substantial areas.
In one embodiment, different values are used for the fast curvature and slow curvature area thresholds. Using the number of beats occurring in the one minute epoch used to set the gain and curvature thresholds, select a desired number of fast and slow characteristic points to find for these beats. For example, in one embodiment, five fast characteristic points per beat and eight slow characteristic point per beat are used as targets. The area thresholds are then adjusted until these target numbers of characteristic points are found. In one embodiment, a lower area limit of 0.1 is used.
In one embodiment, a template is established for classifying beats. For example, a characteristic point template includes a rectangular box covering a time (relative to a fiducial characteristic point) and signal amplitude. The template also includes a curvature area sign.
Rate Estimation
Heart rate, expressed in units of beats per minute, can be determined without relying on detection of individual beats. Mathematically, the heart rate is determined by the number of characteristic points per minute divided by the number characteristic points per beat. The calculation of the number of characteristic points per minute is straightforward. An autocorrelation function is evaluated to determine the number characteristic points per beat.
In one embodiment, the number of characteristic points per beat is calculated by performing the autocorrelation function in the time domain. In one embodiment, the number of characteristic points per beat is calculated by performing the autocorrelation function in the characteristic point domain.
In the series, or stream, of characteristic points describing the input signal, let the individual characteristic points be denoted as CP1, CP2, CP3, . . . , CPn. Each characteristic point has a time value, an area (turn area) value and a voltage value, and for the ith characteristic point, these are denoted as CPi T, CPi A and CPi V, respectively.
The values for the autocorrelations range between +1 and −1. The shift index (k) for the autocorrelations denotes the shift in the characteristic point domain. For example, at k=0, there is no shift and at k=1, the characteristic points are shifted by one.
In one embodiment, the autocorrelation of characteristic points in the characteristic point domain entails, for each value of the shift index k, multiplying like metrics of corresponding characteristic points and summing to produce a value. For example, when k=3, the value of the series includes the sum of the product of CP1V and CP4V, CP2V and CP5V, CP3V and CP6V and so on.
The results are graphically depicted in the autocorrelation plot of
Using exemplary data collected over an epoch having a duration of 6.288 seconds, a total of 80 characteristic points were generated for a rate of 12.722 characteristic points per second. With five characteristic points per beat, the heart rate is calculated as 152.67 beats per minute.
In one embodiment, an autocorrelation is performed using the time differences between successive characteristic points. For example the difference in time for adjacent characteristic points can be expressed as CPi DT=CPi T−CPi−1 T. In addition, the difference in area for adjacent characteristic points can be expressed as CPi DA=CPi A−CPi−1 A and the difference in voltage can be expressed as CPi DV=CPi V−CPi−1 V.
In various embodiments, the difference functions CPi DT, CPi DA and CPi DV are autocorrelated to determine the number of characteristic points per beat. In various embodiments, CPiA, CPiV, CPiDT, CPiDA, and CPiDV are autocorrelated, either alone or in combination (for example, the product CPiV×CPiDT×CPiA), to determine the number of characteristic points per beat.
By way of example, an autocorrelation of the characteristic point voltage values in the characteristic point domain can be expressed as:
where N is the number of characteristic points, CPiV AVG is the average value of the N characteristic point values and k is the index in the characteristic point domain.
In one embodiment, heart rate is found from the autocorrelation of characteristic points in the time domain. In one embodiment, the cardiac signal is reconstructed for autocorrelation from the series of characteristic points. In one embodiment, the reconstruction produces evenly spaced samples for the autocorrelation. In one embodiment, the reconstruction and autocorrelation are performed in closed form using the characteristic point voltages and times from the series of characteristic points.
In one embodiment, only timing information for the characteristic points in the cardiac signal are used for the autocorrelation. In one embodiment, a time difference between successive characteristic point times in the series of characteristic points versus the time of each characteristic point in the series forms a time difference function. In one embodiment, the time difference function is constructed to have evenly spaced samples for autocorrelation. In one embodiment, the autocorrelation of the time difference function is performed in closed form using only the characteristic point times from the series of characteristic points. In general, the first peak of the autocorrelation is equal to the reciprocal of the heart rate.
In one embodiment, heart rate is found from the estimated number of characteristic points per beat and the times of the characteristic points in the series of characteristic points. In one embodiment, an average interval representing one beat is found and the interval is the reciprocal of the heart rate for the rhythm. For example, if the estimate for the number of characteristic points per beat is 5, then the average time interval between each pair of characteristic points that are 5 characteristic points apart is used to find an average time interval for the rhythm as follows:
where Kp is the estimated number of characteristic points per beat.
Other autocorrelations are also contemplated. For example, in various embodiments, the characteristic point voltage values and area values are autocorrelated.
Sub-harmonics in the autocorrelation function can be used to determine the heart rate. The sub-harmonic frequencies are multiples of the fundamental frequency of the heart rate. For example, if the underlying rhythm is a monomorphic ventricular tachycardia (MVT), then the same basic beat shape is repeated at regular intervals. In the characteristic point domain, this means that the autocorrelation plot will have multiple peaks. For example, an autocorrelation plot for a MVT rhythm exhibits a peak at a shift index of 5 as well as the sub-harmonics corresponding to the shift index at 10, 15, and 20.
In one embodiment, the sub-harmonics are used to find the rate. In plot 330 of
In one embodiment, a method to process the autocorrelation provides an improved resolution to find the peaks by incorporating sub-harmonics. As in
Autocorrelation in the time domain can be used for identifying periodicity in a signal. Periodicity can also be identified by performing the time domain autocorrelation of the voltage signal using the characteristic points voltage values. In one embodiment, the time domain signal is represented by straight line segments connecting consecutive characteristic points. The line segment representation of the signal is then autocorrelated using integration of line segments. The endpoints of the line segments are the characteristic points, and thus, the calculations are simplified.
For example, consider a signal described by N characteristic points, where CP1 is the oldest characteristic point, CP2 is the next oldest and so on. A closed form autocorrelation for a given time-lag Q is then computed by sliding each line segment by Q and then integrating (for that line segment) the product of that line segment and the portion of the signal with which it overlaps. The values are obtained for all line segments to find the autocorrelation for the time-lag Q. The same operation is then performed for other values of time-lag to find the time domain autocorrelation (autocorrelation vs. time-lag).
The heart rate can also be determined by autocorrelating a function of the characteristic points in the time domain. For example, in one embodiment, a closed form autocorrelation is calculated, as shown in
Consider a sequence of characteristic point time differences CPi,T where there are N characteristic points. Time difference function 415A is established and has a value, at each characteristic point, equal to the time interval between CPi and CPi+1 as shown with the heavy black line and solid black circles in chart 405. Time function 415A is shifted in time by Q as represented as 415B in chart 410. Each point along the shifted function 415B now falls onto some point of the un-shifted function 415A. For example, point 420B (derived from shifted point 420A) on chart 410, is projected onto point 420C on chart 405. Similarly, the values of the un-shifted function projects onto the time-shifted function. For example, point 425A of chart 405 projects to point 425B of chart 410. The autocorrelation of this function in the time domain is found by determining the area under the product of the curves which is equivalent to adding the area contribution for each portion between the line vertical lines shown in
Next, consider the shifted curve 415B on chart 410. Each segment between the vertical lines is bounded in time by either a shifted or un-shifted characteristic point. Further, these bounding endpoints have a value equal to either the shifted value or the un-shifted value respectively. Each segment also aligns with a second set of values (shown in chart 405) as either un-shifted (solid circles) or shifted (open circles) values. The values for the open circles (chart 405) or open circles (chart 410) are found by shifting the characteristic points either forward (chart 405) or backwards (chart 410) in time. In one embodiment, the calculation of area is found from the shifted line segments, and the corresponding un-shifted line segments. For example, the line segment between 420B and the next point on the shifted function 415B falls entirely on the same line segment after point 430 of the un-shifted function 415A. The values for 420B and 430 are known. Because 415B is a time difference function, the duration after 420B until the next point is also the value of 420B. Thus, the contribution to the autocorrelation integral for this line segment is equal to the value of point 420B squared times the value of the point 430. The autocorrelation is the sum of all line segments.
The time domain autocorrelation of the characteristic points time difference function can be used for estimating rate. Various methods are used to estimate the rate. In some methods, the autocorrelation between 0.15 sec and 0.6 seconds time lag is fit with a straight line via least squares regression and this trend-line is removed from the autocorrelation data in this same range. In one method, a point-by-point scan of the de-trended autocorrelation is performed to find all local peaks. Each local peak, is only then considered if it is faster than the first sub-harmonic of the first such peak. For example, if the first peak in the autocorrelation represents a rate of 300 bpm, then peaks less than or equal to 150 bpm are not considered. All of the peaks remaining in consideration have a specific lag time and an autocorrelation value. In one embodiment, the autocorrelation values are used to weight the rates associated with those peaks to find an average rate for the rhythm.
In one method, the value of the de-trended autocorrelation function in the range from 0.15 to 0.6 seconds time lag and above zero are used to find an average time lag as SUM (corr*lag)/sum(corr). The average time lag is used to find the rate. In this method, the product of each de-trended autocorrelation value that is between 0.15 seconds and 0.6 seconds and greater than zero is multiplied by the corresponding time-lag and summed to find SUM(corr*lag). Also, the de-trended autocorrelation values that meet these criteria are themselves summed to find SUM(corr).
In one embodiment, the average autocorrelation value associated with the peak is used to find the rate.
Other methods are also contemplated for finding the heart rate.
Rhythm Discrimination
In one embodiment, analysis of characteristic points is used to discriminate among different rhythm types.
Rhythm types are associated with a relationship between an atrial cardiac signal and a ventricular cardiac signal. Thus, to discriminate among different types, an atrial input signal and a ventricular input signal are used to generate a series of atrial characteristic points and a series of ventricular characteristic points. In various embodiments, the rhythm can be discriminated by estimating the variation in characteristic point timing and cross-correlations in the characteristic domain. In one embodiment, the relative timing of characteristic points in the atrial and ventricular rate channels is used to discriminate.
In one embodiment, the individual characteristic points in the atrial channel are compared with those in the ventricular channel.
In one embodiment, a time window is established in advance of each ventricular characteristic point. For an appropriately sized window, a characteristic point in the ventricular complex should have one or more atrial characteristic points within the window. Each ventricular characteristic point is considered individually and the number of atrial characteristic points that are contained in such a window is determined.
In one embodiment, a constraint requires that each atrial characteristic point is counted only once. This count is referred to as a forward count and is denoted A:V and is equal to the number of atrial characteristic points which fall in a time window of one or more ventricular characteristic point.
The dimensions of the time window are selected to yield accurate rhythm discrimination results. In one embodiment, the time window is located between 300 milliseconds and 100 milliseconds before a ventricular characteristic point. In one embodiment, the time window is located between 250 milliseconds and 150 milliseconds before a ventricular characteristic point. Other dimensions are also contemplated. In one embodiment, the time window dimensions are selectable based on manual inputs or automatically based on a measured or calculated parameter. In one embodiment, a window dimension is remotely selected and communicated to an implantable device.
Consider the resulting count, for a simple conducted rhythm where each atrial depolarization corresponds with a ventricular depolarization after some delay. In such a case, most of the atrial characteristic points will be counted so that the ratio of counted atrial characteristic points to the total number of atrial characteristic points (denoted as Acnt) will be nearly unity.
In one embodiment, far-field sensing of ventricular depolarizations on the atrial channel may cause additional characteristic points in the atrial channel but these additional characteristic points would generally be simultaneous or later than the ventricular characteristic points so would not fall inside the windows.
If the heart is beating in atrial fibrillation (A-fib), rather than a one-to-one conducted rhythm, then the total atrial characteristic points count will be larger. Also, a smaller percentage of atrial characteristic points, will fall into a ventricular characteristic point window since not all atrial complexes would be conducted and lead to a ventricular complex. Thus, the ratio should become smaller.
If the heart is beating in MVT, polymorphic ventricular tachycardia (PVT) or ventricular fibrillation (VF), then the total number of atrial characteristic points would not increase but a smaller number of characteristic points would be associated with a ventricular characteristic point time window because of the loss of A-V synchrony. On the other hand, more ventricular characteristic points would be present to increase the A:V number. Accordingly, the ratio is unlikely to be greatly affected.
Next, consider the same timings from the point of view of the ventricular characteristic points. Each ventricular characteristic point is analyzed and a count is made of the number of ventricular characteristic points that have at least one atrial characteristic point within a time window for the ventricular characteristic point. This count is referred to as a backward count and is denoted V:A and is equal to the number of ventricular characteristic points which have one or more atrial characteristic points in the advance time window.
For a one-to-one conducted rhythm, most of the ventricular characteristic points will meet the criteria so that the ratio of counted ventricular characteristic points to the total number of ventricular characteristic points (Vcnt) will be nearly unity.
If the heart rhythm was actually A-fib instead of a one-to-one conducted rhythm, then the total number of ventricular characteristic points would be greater reflecting an elevated rate. However, since each ventricular complex would be from a conducted atrial complex, the percentage of ventricular characteristic points that are associated with atrial characteristic points would remain about the same even though there are more ventricular characteristic points.
If the actual rhythm was an MVT or PVT/VF, then the total number of ventricular characteristic points would increase and a smaller number would be associated with an atrial characteristic point in their time window. Accordingly, the ratio would also be reduced.
The ventricular and atrial characteristic points are found over the selected epoch. If the rhythm is one-to-one conduction, then there is the same number of beats in each channel. Without knowing the number of beats in the epoch, an estimate can be made for the number of atrial characteristic points per beat relative to the number of ventricular characteristic points per beat, denoted here as Acnt/Vcnt.
If the rhythm is one-to-one, then the percentage of atrial characteristic points associated with ventricular characteristic points should approximate the percentage of ventricular characteristic points associated with atrial characteristic points, however, the number of characteristic points per beat may be different in the two channels.
In various embodiments, the value V:A/Vcnt or the value [(A:V/Acnt)/(V:A/Vcnt)]/[Acnt/Vcnt], which can be rewritten as (Vcnt/Acnt)2/(A:V*V/A), is used to discriminate among rhythms.
In one embodiment, a plot is generated to graphically illustrate the relationship between atrial characteristic points and ventricular characteristic points. In
The different regions of the X-Y plane correspond to the different rhythm types. For example, the SVT rhythms fall generally in the range below about 150 on the Y-axis and between 50 to 100 on the X-axis. In contrast, VT rhythms generally fall much closer to zero on the X-axis reflecting the expected strong decrease of V:A/Vcnt. Furthermore, the VT rhythms fall higher on the Y-axis since Vcnt is generally higher.
In one embodiment, an X and Y value for a rhythm is found by processing the timings of the atrial and ventricular characteristic points according to the present subject matter. In one embodiment, the position of the X and Y values on the plot is used for classifying the rhythm. In one embodiment, the classification is between either SVT or VT. In one embodiment, the classification is made by comparing the X-Y point with fixed boundaries on the plot. In one embodiment, the boundaries are comprised of one or more straight line segments. In one embodiment, the rhythm is classified as SVT if the X-Y point falls on one side of the boundary and is classified as VT if it falls on the opposite side of the boundary.
Other embodiments are also contemplated. For example, in one embodiment, a window is established after each atrial characteristic point and counts are established based on the relative timing of atrial characteristic points and ventricular characteristic points.
Other metrics are also contemplated for discriminating among rhythm types. For example, in one embodiment, discrimination is based on the percentage of atrial characteristic points that are not associated with a ventricular characteristic points or a value derived from ventricular characteristic points.
Exemplary Device
In one embodiment, the present subject matter includes circuitry, hardware and software for implantation in a body. In one embodiment, the present subject matter is adapted for use external to a body.
In one embodiment, unit 503 includes input circuit 515, controller 520, telemetry circuit 525, memory 530 and therapy circuit 535. Input circuit 515 is coupled to lead 510 and receives an analog signal based on cardiac activity of heart 505. In one embodiment, input circuit 515 includes an analog-to-digital converter.
In one embodiment, controller 520 includes a processor and programming to implement a method as described herein. In one embodiment, controller 520 includes a circuit to control therapy circuit 535 and telemetry circuit 525.
Memory 530 is coupled to controller 520 and provides data storage. In one embodiment, the input signal is sampled and characteristic points are generated substantially in real-time. In one embodiment, characteristic points are generated based on stored sample data derived from the input signal. In one embodiment, programming executing on a processor of controller 520 is stored in memory 530.
In one embodiment, controller 520 determines what therapy or electrical stimulation is to be delivered by therapy circuit 535 to heart 505 using lead 540.
In one embodiment, controller 520 determines what data is to be communicated using telemetry circuit 525. Telemetry circuit 525, in various embodiments is adapted to provide wired or wireless telemetry.
In one embodiment, controller 520 executes programming to determine curvature of an input signal and generates characteristic points.
In one embodiment, controller 520 includes a comparator which generates an output based on a comparison of an input signal and a reference signal. Exemplary comparisons include determining if the lobe is making a positive or negative excursion from a baseline. In one embodiment, an exemplary comparison includes determining if the curvature series lobe is greater or less than a dead-zone threshold. In one embodiment, an exemplary comparison includes comparing the curvature signal with a hysteresis value of a threshold.
In the figure, two leads are shown coupled to heart 505. In one embodiment, a single lead provides both sensing and therapy for heart 505.
System 500, in one embodiment, is adapted to determine a heart rate according to the methods described herein. The heart rate is then stored in memory 530. In one embodiment, the heart rate is used to determine appropriate therapy or to confirm application of a particular therapy. In one embodiment, a first heart rate is determined by a method described herein and a second heart rate is determined by an auxiliary method and controller 520 reconciles the first heart rate and second heart rate to determine a third heart rate. In one embodiment, the heart rate is communicated to a remote programmer by telemetry circuit 525.
System 500, in one embodiment, is adapted to classify a rhythm according to the methods described herein. The rhythm classification is then stored in memory 530. In one embodiment, the classification is used to determine appropriate therapy or to confirm application of a particular therapy. In one embodiment, a first classification is determined by a method described herein and a second classification for the same epoch is determined by an auxiliary method and controller 520 reconciles the first classification and second classification to determine a third classification. In one embodiment, the classification is communicated to a remote programmer by telemetry circuit 525.
Alternative Embodiments
Characteristic points can be described in terms of a size corresponding to the area of a lobe in the curvature series. In one embodiment, before calculating a heart rate or classifying a rhythm type according to a method described herein, the series of characteristic points are filtered based on their size. In one embodiment, this entails selecting only those characteristic points having a size greater than a predetermined value for use in determining a heart rate or rhythm classification. In one embodiment, other filtering criteria is applied to the series of characteristic points before determining a rate or rhythm.
In one embodiment, a rhythm is classified based on a straight line in the X-Y plane. In one embodiment, an irregular shaped region is described in the x-y plane and the cluster of data points in the plane relative to the region provides the basis for discrimination. In one embodiment, probability functions are calculated for the data points and serve as discrimination criteria.
In one embodiment, other discrimination techniques are used in conjunction with those described herein and a processor resolves any differences and makes a classification selection.
In one embodiment, a method described herein is executed by hardwired circuitry. The circuitry may be analog or digital and include circuit elements such as operational amplifiers or logic gates.
Conclusion
The above description is intended to be illustrative, and not restrictive. Many other embodiments will be apparent to those of skill in the art upon reviewing the above description.
Sweeney, Robert J., Ricci, Carlos
Patent | Priority | Assignee | Title |
10016143, | Aug 18 2014 | Cameron Health, Inc. | Peak selection for self correlation analysis of cardiac rate in an implantable medical device |
10123742, | Dec 02 2015 | Cardiac Pacemakers, Inc. | Methods and devices combining multiple cardiac rate measurements with interval correction and arrhythmia decision bypass |
10426405, | Dec 02 2015 | Cardiac Pacemakers, Inc. | Methods and devices combining multiple cardiac rate measurements with activation and arrhythmia analysis correction |
9451892, | Aug 18 2014 | Cameron Health, Inc. | Cardiac rate tracking in an implantable medical device |
9451893, | Aug 18 2014 | Cameron Health, Inc. | Calculation of self-correlation in an implantable cardiac device |
9629565, | Aug 18 2014 | Cameron Health, Inc. | Peak selection for self correlation analysis of cardiac rate in an implantable medical devices |
9895071, | Aug 18 2014 | Cameron Health, Inc. | Cardiac rate tracking in an implantable medical device |
Patent | Priority | Assignee | Title |
3828768, | |||
3939824, | Oct 09 1973 | MARQUETTE ELECTRONICS, INC | Physiological waveform detector |
3998214, | May 19 1975 | Brondy Laboratories, Inc. | Premature ventricular contraction detector and method |
4000461, | Oct 04 1973 | SPACELABS,INC A CORP OF CA | R-wave detector |
4023564, | Jan 26 1976 | SpaceLabs, Inc. | Arrhythmia detector |
4336810, | Sep 30 1980 | Del Mar Avionics | Method and apparatus for arrhythmia analysis of ECG recordings |
4523595, | Nov 25 1981 | Method and apparatus for automatic detection and treatment of ventricular fibrillation | |
4531527, | Apr 23 1982 | Brunswick Biomedical Corporation | Ambulatory monitoring system with real time analysis and telephone transmission |
4583553, | Nov 15 1983 | MEDICOMP, INC | Ambulatory ECG analyzer and recorder |
4589420, | Jul 13 1984 | SPACELABS, INC , A CORP OFCA | Method and apparatus for ECG rhythm analysis |
4637400, | Feb 15 1985 | For characterizing a heart condition | |
4721114, | Feb 21 1986 | Cardiac Pacemakers, Inc. | Method of detecting P-waves in ECG recordings |
4802491, | Jul 30 1986 | Massachusetts Institute of Technology | Method and apparatus for assessing myocardial electrical stability |
4809697, | Oct 14 1987 | Pacesetter, Inc | Interactive programming and diagnostic system for use with implantable pacemaker |
4825869, | Sep 28 1987 | Pacesetter, Inc | System for automatically performing a clinical assessment of an implanted pacer based on information that is telemetrically received |
4832038, | Jun 05 1985 | The Board of Trustees of University of Illinois | Apparatus for monitoring cardiovascular regulation using heart rate power spectral analysis |
4838278, | Feb 26 1987 | Koninklijke Philips Electronics N V | Paced QRS complex classifier |
4884345, | May 12 1988 | Pacesetter, Inc | Adjustable template for pacemaker ECG analysis and method of use |
4924875, | Oct 09 1987 | ASPECT MEDICAL SYSTEMS, INC | Cardiac biopotential analysis system and method |
4945917, | May 29 1987 | AKSELROD, SOLANG; KARIN, JACOB; HIRSCH, MICHAEL | Method and apparatus for indicating repetition intervals of a specified component of a composite electrical signal, particularly useful for displaying fetal r-waves |
4947857, | Feb 01 1989 | ARRHYTHMIA RESEARCH TECHNOLOGY, INC | Method and apparatus for analyzing and interpreting electrocardiograms using spectro-temporal mapping |
4989610, | Nov 16 1987 | SPACELABS, INC | Method and system of ECG data review and analysis |
4996984, | Sep 26 1989 | Cardiac Pacemakers, Inc | Defibrillation method |
5000189, | Nov 15 1989 | SOUTHERN FESTIVE FOODS, INC , A CORP OF GA | Method and system for monitoring electrocardiographic signals and detecting a pathological cardiac arrhythmia such as ventricular tachycardia |
5014284, | Jun 30 1989 | INDUSIND BANK LIMITED | Discrete slope delta modulation with recovery means |
5014698, | Oct 06 1987 | Medtronic, Inc | Method of and system for monitoring and treating a malfunctioning heart |
5020540, | Oct 09 1987 | ASPECT MEDICAL SYSTEMS, INC | Cardiac biopotential analysis system and method |
5046504, | Feb 01 1989 | ARRHYTHMIA RESEARCH TECHNOLOGY, INC | Method and apparatus for analyzing and interpreting electrocardiograms using spectro-temporal mapping |
5107850, | Nov 02 1990 | Cardiac Pacemakers, Inc. | Method and apparatus for classifying and treating cardiac arrhythmias based on atrial and ventricular activity |
5109842, | Sep 24 1990 | Pacesetter, Inc | Implantable tachyarrhythmia control system having a patch electrode with an integrated cardiac activity system |
5139028, | Oct 26 1990 | Pacesetter, Inc | Heart rejection monitoring apparatus and method |
5156148, | Oct 06 1987 | Medtronic, Inc | System for treating a malfunctioning heart |
5184615, | Mar 08 1991 | Pacesetter, Inc | Apparatus and method for detecting abnormal cardiac rhythms using evoked potential measurements in an arrhythmia control system |
5193550, | Nov 30 1990 | Medtronic, Inc. | Method and apparatus for discriminating among normal and pathological tachyarrhythmias |
5201321, | Feb 11 1991 | BIO-DIMENSIONS, INC , | Method and apparatus for diagnosing vulnerability to lethal cardiac arrhythmias |
5215098, | Aug 12 1991 | Pacesetter, Inc | Data compression of cardiac electrical signals using scanning correlation and temporal data compression |
5217021, | Jul 30 1991 | Pacesetter, Inc | Detection of cardiac arrhythmias using correlation of a cardiac electrical signals and temporal data compression |
5228438, | Oct 08 1991 | Pacesetter, Inc | Implantable pacemaker including means and method of terminating a pacemaker-mediated tachycardia during rate adaptive pacing |
5240009, | Mar 25 1991 | Pacesetter, Inc | Medical device with morphology discrimination |
5247021, | Jun 06 1989 | Kanegafuchi Kagaku Kogyo Kabushiki Kaisha | Process for preparation of a polymer having reactive terminal group |
5255186, | Aug 06 1991 | Pacesetter, Inc | Signal averaging of cardiac electrical signals using temporal data compression and scanning correlation |
5266554, | Aug 31 1990 | Ciba-Geigy Corporation | Heterocyclic compounds |
5269301, | Oct 06 1987 | Medtronic, Inc | Multimode system for monitoring and treating a malfunctioning heart |
5271411, | Sep 21 1990 | OMRON HEALTHCARE CO , LTD | Method and apparatus for ECG signal analysis and cardiac arrhythmia detection |
5273049, | Apr 09 1992 | Pacesetter, Inc | Detection of cardiac arrhythmias using template matching by signature analysis |
5275621, | Apr 13 1992 | Medtronic, Inc. | Method and apparatus for terminating tachycardia |
5280792, | Sep 20 1991 | UNIVERSITY OF SYDNEY, THE | Method and system for automatically classifying intracardiac electrograms |
5291400, | Apr 09 1992 | SpaceLabs Medical, Inc.; SPACELABS, INC , A CORP OF CA | System for heart rate variability analysis |
5292341, | Mar 02 1992 | Pacesetter, Inc | Method and system for determining and automatically adjusting the sensor parameters of a rate-responsive pacemaker |
5292348, | Jun 14 1991 | Pacesetter, Inc | Implantable cardioverter/defibrillator and method employing cross-phase spectrum analysis for arrhythmia detection |
5311874, | May 18 1992 | Cardiac Pacemakers, Inc. | Method for tachycardia discrimination |
5312445, | Feb 03 1992 | Pacesetter, Inc | Implantable cardiac stimulating apparatus and method employing detection of P-waves from signals sensed in the ventricle |
5313953, | Jan 14 1992 | Cardiac Pacemakers, Inc | Implantable cardiac patient monitor |
5330504, | Mar 16 1992 | Pacesetter, Inc | Cardioverting defibrillating device with off-line ECG analysis |
5331966, | Apr 05 1991 | Medtronic, Inc. | Subcutaneous multi-electrode sensing system, method and pacer |
5334220, | Nov 13 1992 | Pacesetter, Inc | Dual-chamber implantable pacemaker having an adaptive AV interval that prevents ventricular fusion beats and method of operating same |
5342402, | Jan 29 1993 | Medtronic, Inc. | Method and apparatus for detection and treatment of tachycardia and fibrillation |
5350406, | Dec 31 1991 | ELA Medical | Apparatus and method of control for an implanted anti-tachycardia device |
5351696, | Apr 23 1993 | Medtronic, Inc.; DUTHLER, REED A | Method and apparatus for intracardiac electrogram morphologic analysis |
5360436, | Apr 03 1992 | ADVANCED MEDICAL DEVICES, S A | Cardiac pacing responsive to multiple activity types |
5365934, | Jun 28 1991 | Brunswick Corporation | Apparatus and method for measuring heart rate |
5366487, | Mar 09 1992 | Angeion Corporation | Fibrillation and tachycardia detection |
5379776, | Apr 01 1993 | Pacesetter, Inc | Heart rhythm classification method, and implantable dual chamber cardioverter/defibrillator employing the same |
5383910, | Feb 19 1993 | Medtronic, Inc. | Method and apparatus for tachyarrhythmia detection and treatment |
5387229, | Jan 21 1993 | Pacesetter, Inc | Multi-sensor cardiac pacemaker with sensor event recording capability |
5388578, | Jan 14 1992 | Cardiac Pacemakers, Inc | Electrode system for use with an implantable cardiac patient monitor |
5391189, | Nov 04 1993 | Vitatron Medical, B.V. | Rate adaptive dual chamber pacing system and method with automatic adjustment of operating parameters for minimizing sensor-sinus competition |
5400795, | Oct 22 1993 | Pacesetter, Inc | Method of classifying heart rhythms by analyzing several morphology defining metrics derived for a patient's QRS complex |
5411031, | Nov 24 1993 | Cardiac Pacemakers, Inc | Implantable cardiac patient monitor |
5411529, | Aug 10 1990 | Medtronic, Inc.; DUTHLER, REED A | Waveform discriminator for cardiac stimulation devices |
5417221, | May 29 1990 | Psytech, Inc. | Method and apparatus for distinguishing electric signal waveforms |
5417714, | Mar 05 1992 | Pacesetter, Inc | DDI pacing with PVC-protected hysteresis and automatic AV interval adjustment |
5421830, | Aug 27 1993 | Pacesetter, Inc | Programming system having means for recording and analyzing a patient's cardiac signal |
5431693, | Dec 10 1993 | Intermedics, Inc.; INTERMEDICS, INC | Method of verifying capture of the heart by a pacemaker |
5447519, | Mar 19 1994 | Medtronic, Inc. | Method and apparatus for discrimination of monomorphic and polymorphic arrhythmias and for treatment thereof |
5447524, | Apr 03 1992 | Intermedics, Inc. | Cardiac pacing method and apparatus responsive to multiple activity types |
5456261, | Dec 16 1993 | Marquette Electronics, Inc. | Cardiac monitoring and diagnostic system |
5458620, | Feb 20 1992 | ELA MEDICAL, S A | Cardiac arrhythmia detection using interdependent multiple parameter settings |
5458623, | Mar 04 1994 | Pacesetter, Inc | Automatic atrial pacing threshold determination utilizing an external programmer and a surface electrogram |
5464433, | Jun 14 1994 | Cardiac Pacemakers, Inc | Atrial defibrillator and method providing dual reset of an interval timer |
5478807, | Aug 19 1991 | BAS MEDICAL, INC | Use of relaxin in the treatment of bradycardia |
5480412, | Nov 16 1993 | Pacesetter, Inc | System and method for deriving hemodynamic signals from a cardiac wall motion sensor |
5487754, | Mar 02 1992 | Pacesetter, Inc. | Method and apparatus for reporting and displaying a sequential series of pacing events |
5503159, | Mar 12 1993 | Koninklijke Philips Electronics N V | Method for enhancement of late potentials measurements |
5509927, | Aug 27 1993 | Pacesetter, Inc. | Programming system having means for recording and analyzing a patient's cardiac signal |
5511554, | Oct 12 1993 | Agilent Technologies Inc | Real-time artifact removal from waveforms using a dynamic filter having a fixed delay |
5513644, | Dec 01 1992 | Pacesetter, Inc.; SIEMENS PACESETTER, INC | Cardiac arrhythmia detection system for an implantable stimulation device |
5514163, | Feb 21 1995 | Medtronic, Inc | Dual chamber pacing system and method with optimized adjustment of the AV escape interval for treating cardiomyopathy |
5520191, | Oct 07 1994 | Ortivus AB | Myocardial ischemia and infarction analysis and monitoring method and apparatus |
5542430, | Sep 16 1994 | Pacesetter, Inc | Apparatus and method for discriminating between cardiac rhythms on the basis of their morphology using a neural network |
5545186, | Mar 30 1995 | Medtronic, Inc | Prioritized rule based method and apparatus for diagnosis and treatment of arrhythmias |
5549641, | Oct 31 1994 | Cardiac Pacemakers, Inc | Atrial fibrillation type selective cardiovertor and method |
5549654, | Apr 15 1994 | Medtronic, Inc. | Interactive interpretation of event markers in body-implantable medical device |
5560369, | Dec 01 1992 | Pacesetter, Inc.; SIEMENS PACESETTER, INC | Cardiac arrhythmia detection system for an implantable stimulation device and method |
5603331, | Feb 12 1996 | Cardiac Pacemakers, Inc. | Data logging system for implantable cardiac device |
5605159, | Feb 16 1996 | System and method for determining spatial organization of atrial activation | |
5609158, | May 01 1995 | ARRHYTHMIA RESEARCH TECHNOLOGY, INC | Apparatus and method for predicting cardiac arrhythmia by detection of micropotentials and analysis of all ECG segments and intervals |
5622178, | May 04 1994 | SPACELABS MEDICAL, INC | System and method for dynamically displaying cardiac interval data using scatter-plots |
5628326, | Nov 29 1995 | Koninklijke Philips Electronics N V | Calculating a heart rate from an ECG waveform by discarding a percentage of R-R intervals prior to averaging |
5634468, | Apr 03 1992 | VECTRACOR, INC | Sensor patch and system for physiological monitoring |
5645070, | Sep 25 1995 | Pacesetter, Inc | Method and apparatus for determining the origins of cardiac arrhythmias morphology dynamics |
5676153, | Feb 16 1996 | Cardiac Pacemakers, Inc | System and method for determining spatial organization of atrial activation |
5682900, | Nov 29 1995 | Koninklijke Philips Electronics N V | Method and apparatus for obtaining heartbeat measurements from a ECG waveform |
5682902, | Oct 16 1995 | Koninklijke Philips Electronics N V | ECG pace pulse detection and processing |
5683425, | Dec 12 1994 | Pacesetter AB | Heart pacemaker with improved detection of electrical signals |
5685315, | Dec 01 1992 | Pacesetter, Inc. | Cardiac arrhythmia detection system for an implantable stimulation device |
5687737, | Oct 09 1992 | Washington University | Computerized three-dimensional cardiac mapping with interactive visual displays |
5697959, | Jan 11 1996 | Pacesetter, Inc. | Method and system for analyzing and displaying complex pacing event records |
5704365, | Nov 14 1994 | SPACELABS HEALTHCARE, INC | Using related signals to reduce ECG noise |
5712801, | Sep 25 1995 | Pacesetter, Inc | Method for characterizing dynamical systems |
5713366, | Sep 16 1996 | Sulzer Intermedics Inc. | Method and apparatus for dual chamber cardiac analysis |
5713367, | Jan 26 1994 | SPACELABS HEALTHCARE, INC | Measuring and assessing cardiac electrical stability |
5718242, | Dec 01 1992 | Pacesetter, Inc | Cardiac arrhythmia detection system for an implantable stimulation device and method |
5724985, | Aug 02 1995 | Pacesetter, Inc.; Pacesetter, Inc | User interface for an implantable medical device using an integrated digitizer display screen |
5730142, | Dec 04 1996 | Medtronic, Inc. | Method and apparatus for detecting tachycardia |
5738104, | Nov 08 1995 | Salutron, Inc | EKG based heart rate monitor |
5738105, | Oct 24 1995 | Angeion Corporation | Method and apparatus for sensing R-waves using both near field and far field sensing simultaneously |
5749900, | Dec 11 1995 | Sulzer Intermedics Inc.; INTERMEDICS, INC | Implantable medical device responsive to heart rate variability analysis |
5755739, | Dec 04 1996 | Medtronic, Inc. | Adaptive and morphological system for discriminating P-waves and R-waves inside the human body |
5758654, | Aug 29 1996 | Harley Street Software Ltd. | ECG P QRS T onset and peak detection method |
5759158, | Jul 28 1995 | Boston Scientific Scimed, Inc | Systems and methods for conducting electrophysiological testing using high-voltage energy pulses to stun heart tissue |
5772604, | Mar 14 1997 | Emory University | Method, system and apparatus for determining prognosis in atrial fibrillation |
5778881, | Dec 04 1996 | Medtronic, Inc. | Method and apparatus for discriminating P and R waves |
5779645, | Dec 17 1996 | Pacesetter, Inc | System and method for waveform morphology comparison |
5782888, | Dec 04 1996 | Medtronic, Inc. | Method of selecting an operating mode for an implantable medical device |
5788717, | Jul 11 1995 | Pacesetter, Inc.; Pacesetter, Inc | Atrial rate determination and atrial tachycardia detection in a dual-chamber implantable pacemaker |
5792065, | Mar 18 1997 | Marquette Medical Systems, Inc. | Method and apparatus for determining T-wave marker points during QT dispersion analysis |
5792066, | Jan 09 1997 | Koninklijke Philips Electronics N V | Method and system for detecting acute myocardial infarction |
5795303, | Feb 17 1995 | EP Technologies, Inc. | Systems and methods for making time-sequential measurements of biopotentials sensed in myocardial tissue |
5797399, | Apr 19 1996 | The Regents of the University of Michigan | Method and apparatus for identifying and correctly responding to abnormal heart activity |
5797849, | Mar 28 1995 | Sonometrics Corporation | Method for carrying out a medical procedure using a three-dimensional tracking and imaging system |
5810739, | Dec 19 1996 | Pacesetter, Inc | Methods and apparatus for classifying cardiac events with an implantable cardiac device |
5814077, | Nov 13 1992 | Pacesetter, Inc.; Pacesetter, Inc | Pacemaker and method of operating same that provides functional atrial cardiac pacing with ventricular support |
5817133, | Mar 04 1997 | Medtronic, Inc. | Pacemaker with morphological filtering of sensed cardiac signals |
5819007, | Mar 15 1996 | Draeger Medical Systems, Inc | Feature-based expert system classifier |
5819741, | Oct 07 1994 | Ortivus AB | Cardiac monitoring system and method |
5827195, | May 09 1997 | SPACELABS HEALTHCARE, INC | Electrocardiogram noise reduction using multi-dimensional filtering |
5827197, | Nov 14 1997 | Cardiac Pacemakers, Inc | System for detecting atrial fibrillation notwithstanding high and variable ventricular rates |
5836889, | Mar 04 1996 | BIOTRONIK MESS - UND THERAPIEGERAETE GMBH & CO | Method and apparatus for storing signals in an implantable medical device |
5836987, | Nov 15 1995 | Cardiac Pacemakers, Inc. | Apparatus and method for optimizing cardiac performance by determining the optimal timing interval from an accelerometer signal |
5848972, | Sep 13 1996 | CHILDREN S MEDICAL CENTER CORPORATION | Method for endocardial activation mapping using a multi-electrode catheter |
5855593, | Mar 30 1995 | Medtronic, Inc. | Prioritized rule based method and apparatus for diagnosis and treatment for arrhythmias |
5857977, | Aug 08 1996 | REGENTS OF THE UNIVERSITY OF MICHIGAN, THE | Method and apparatus for separation of ventricular tachycardia from ventricular fibrillation for implantable cardioverter defibrillators |
5858977, | Oct 13 1994 | BIOVITRUM AB PUBL | Method of treating diabetes mellitus using KGF |
5868680, | Sep 23 1997 | The Regents of the University of California | Quantitative characterization of fibrillatory spatiotemporal organization |
5873897, | Sep 19 1997 | Sulzer Intermedics Inc.; SULZER INTERMEDICS INC | Method and apparatus for dual chambered tachyarrhythmia classification and therapy |
5873898, | Apr 29 1997 | Medtronic, Inc | Microprocessor capture detection circuit and method |
5935082, | Jan 26 1995 | SPACELABS HEALTHCARE, INC | Assessing cardiac electrical stability |
5941831, | Apr 03 1998 | Pacesetter, Inc. | Method for diagnosing cardiac arrhythmias using interval irregularity |
5944744, | Feb 06 1998 | Intermedics Inc | Implantable cardiac stimulator with automatic electrogram profiling |
5951592, | Nov 21 1997 | Pacesetter, Inc. | Apparatus and method for applying antitachycardia therapy based on ventricular stability |
5954661, | Mar 31 1997 | BOSTON SCIENTIFIC SCIENTIFIC SCIMED, INC ; Boston Scientific Scimed, Inc | Tissue characterization and treatment using pacing |
5957857, | May 07 1998 | Cardiac Pacemakers, Inc. | Apparatus and method for automatic sensing threshold determination in cardiac pacemakers |
5978700, | May 06 1998 | BIOTRONIK MESS- UND THERAPIEGERAETE GMBH & CO INGENIETRBUERO BERLIN | Recognizing ventricular tachycardia condition using dual chamber sense information |
5978707, | Apr 30 1997 | Cardiac Pacemakers, Inc. | Apparatus and method for treating ventricular tachyarrhythmias |
5983138, | Apr 04 1997 | Cardiac Pacemakers, Inc. | Device and method for ventricular tracking and pacing |
5984954, | Oct 01 1997 | Boston Medical Technologies, Inc. | Methods and apparatus for R-wave detection |
5991656, | Mar 30 1995 | Medtronic, Inc. | Prioritized rule based apparatus for diagnosis and treatment of arrhythmias |
5991657, | Aug 06 1998 | Cardiac Pacemakers, Inc | Atrial cardioverter with window based atrial tachyarrhythmia detection system and method |
6016442, | Mar 25 1998 | Cardiac Pacemakers, Inc | System for displaying cardiac arrhythmia data |
6024705, | Nov 06 1998 | Bioacoustics, Inc. | Automated seismic detection of myocardial ischemia and related measurement of cardiac output parameters |
6049735, | Mar 01 1999 | Cardiac Pacemakers Inc. | Cardiac rhythm management device with detection and therapy for sudden syncopal events |
6052617, | Jul 01 1998 | Cardiac Pacemakers, Inc | System and method for reliably detecting atrial events of a heart using only atrial sensing |
6076014, | Aug 01 1997 | Medtronic, Inc | Cardiac stimulator and defibrillator with means for identifying cardiac rhythm disorder and chamber of origin |
6081745, | Aug 17 1998 | Medtronic, Inc. | Method and apparatus for treatment of arrhythmias |
6091990, | Mar 25 1998 | Cardiac Pacemakers, Inc. | System for grouping and displaying cardiac arrhythmia data |
6108577, | Apr 26 1999 | Cardiac Pacemakers, Inc | Method and apparatus for detecting changes in electrocardiogram signals |
6161037, | Oct 01 1997 | Boston Medical Technologies, Inc. | Methods and apparatus for R-wave detection |
6192273, | Dec 02 1997 | The Cleveland Clinic Foundation; CLEVELAND CLINIC FOUNDATION, THE | Non-programmable automated heart rhythm classifier |
6212428, | Jun 17 1998 | Cardiac Pacemakers, Inc. | Multiple stage morphology-based system detecting ventricular tachycardia and supraventricular tachycardia |
6223078, | Mar 12 1999 | Cardiac Pacemakers, Inc | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
6233072, | Dec 31 1997 | Verizon Patent and Licensing Inc | Method and system for restoring coincident line and facility failures |
6233078, | Apr 25 1997 | NEC Corporation | Photo signal amplification transmission system |
6233487, | Jun 08 1999 | SANDLEFORD PARK LIMITED, AS SECURITY AGENT | Apparatus and method for setting the parameters of an alert window used for timing the delivery of ETC signals to a heart under varying cardiac conditions |
6253102, | Mar 25 1998 | Cardiac Pacemakers, Inc. | System for displaying cardiac arrhythmia data |
6263242, | Mar 25 1999 | SANDLEFORD PARK LIMITED, AS SECURITY AGENT | Apparatus and method for timing the delivery of non-excitatory ETC signals to a heart |
6266554, | Feb 12 1999 | Cardiac Pacemakers, Inc | System and method for classifying cardiac complexes |
6272377, | Oct 01 1999 | Cardiac Pacemakers, Inc | Cardiac rhythm management system with arrhythmia prediction and prevention |
6275732, | Jun 17 1998 | Cardiac Pacemakers, Inc | Multiple stage morphology-based system detecting ventricular tachycardia and supraventricular tachycardia |
6301499, | Jun 08 1998 | Cardiac Pacemakers, Inc. | Heart rate variability as an indicator of exercise capacity |
6301503, | Mar 25 1998 | Cardiac Pacemakers, Inc. | System for grouping and displaying cardiac arrhythmia data |
6308095, | Feb 12 1999 | Cardiac Pacemakers, Inc | System and method for arrhythmia discrimination |
6312388, | Mar 12 1999 | Cardiac Pacemakers, Inc | Method and system for verifying the integrity of normal sinus rhythm templates |
6370430, | Mar 25 1999 | SANDLEFORD PARK LIMITED, AS SECURITY AGENT | Apparatus and method for controlling the delivery of non-excitatory cardiac contractility modulating signals to a heart |
6400982, | Oct 01 1999 | Cardiac Pacemakers, Inc. | Cardiac rhythm management system with arrhythmia prediction and prevention |
6430435, | Jun 17 1998 | Cardiac Pacemakers, Inc. | Multiple state morphology-based system detecting ventricular tachycardia and supraventricular tachycardia |
6430438, | May 21 1999 | Cardiac Pacemakers, Inc.; Cardiac Pacemakers, Inc | Cardiac rhythm management system with atrial shock timing optimization |
6434417, | Mar 28 2000 | Cardiac Pacemakers, Inc | Method and system for detecting cardiac depolarization |
6438410, | Feb 12 1998 | Cardiac Pacemakers, Inc. | System and method for a classifying cardiac complexes |
6449503, | Jul 14 1999 | Cardiac Pacemakers, Inc | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm |
6470210, | Apr 06 2001 | Cardiac Pacemakers, Inc | System and method for continuously monitoring classified atrial arrhythmias |
6484055, | Mar 12 1999 | Cardiac Pacemakers, Inc. | Discrimination of supraventricular tachycardia and ventricular tachycardia events |
6516219, | Aug 15 2000 | Pacesetter, Inc.; Pacesetter, Inc | Arrhythmia forecasting based on morphology changes in intracardiac electrograms |
6516225, | Dec 28 1999 | Pacesetter, Inc.; Pacesetter, Inc | System and method for distinguishing electrical events originating in the atria from far-field electrical events originating in the ventricles as detected by an implantable medical device |
6539257, | Jan 30 1998 | UAB Research Foundation | Method and apparatus for treating cardiac arrhythmia |
6571121, | Dec 11 1995 | Intermedics Inc. | Implantable medical device responsive to heart rate variability analysis |
6684100, | Oct 31 2000 | Cardiac Pacemakers, Inc | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
6708058, | Apr 30 2001 | Cardiac Pacemakers, Inc | Normal cardiac rhythm template generation system and method |
6728572, | Feb 12 1999 | Cardiac Pacemakers, Inc. | System and method for classifying cardiac complexes |
6745068, | Nov 28 2000 | Medtronic, Inc | Automated template generation algorithm for implantable device |
6760615, | Oct 31 2001 | Medtronic, Inc | Method and apparatus for discriminating between tachyarrhythmias |
6766190, | Oct 31 2001 | Medtronic, Inc | Method and apparatus for developing a vectorcardiograph in an implantable medical device |
6889081, | Jul 14 1999 | Cardiac Pacemakers, Inc. | Classification of supraventricular and ventricular cardiac rhythms using cross channel timing algorithm |
6950702, | Jul 15 2002 | Cardiac Pacemakers, Inc | Use of curvature based features for beat detection |
7289845, | Oct 31 2000 | Cardiac Pacemakers, Inc. | Curvature based method for selecting features from an electrophysiologic signal for purpose of complex identification and classification |
7500955, | Jun 27 2003 | Cardiac Pacemakers, Inc | Signal compression based on curvature parameters |
7792571, | Jun 27 2003 | Cardiac Pacemakers, Inc | Tachyarrhythmia detection and discrimination based on curvature parameters |
20020032469, | |||
20020087091, | |||
20020091333, | |||
20020183637, | |||
20020183639, | |||
20020193696, | |||
20030069511, | |||
20030083586, | |||
20030083587, | |||
20030100923, | |||
20030181818, | |||
20040010200, | |||
20040093035, | |||
20040127806, | |||
20040176694, | |||
20040215244, | |||
20040267143, | |||
20050159781, | |||
20070203419, | |||
20090192395, | |||
DE4405827, | |||
EP469817, | |||
EP506230, | |||
EP554208, | |||
EP711531, | |||
EP776630, | |||
EP776631, | |||
EP848965, | |||
EP469817, | |||
EP506230, | |||
EP554208, | |||
RE35148, | Jan 20 1995 | Riverside Research Institute | Frequency diversity for image enhancement |
WO10455, | |||
WO47278, | |||
WO141870, | |||
WO240094, | |||
WO2005002669, | |||
WO9739681, | |||
WO9853879, | |||
WO9965570, |
Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
Aug 11 2010 | Cardiac Pacemakers, Inc. | (assignment on the face of the patent) | / |
Date | Maintenance Fee Events |
Mar 14 2013 | ASPN: Payor Number Assigned. |
Sep 15 2016 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
Nov 23 2020 | REM: Maintenance Fee Reminder Mailed. |
May 10 2021 | EXP: Patent Expired for Failure to Pay Maintenance Fees. |
Date | Maintenance Schedule |
Apr 02 2016 | 4 years fee payment window open |
Oct 02 2016 | 6 months grace period start (w surcharge) |
Apr 02 2017 | patent expiry (for year 4) |
Apr 02 2019 | 2 years to revive unintentionally abandoned end. (for year 4) |
Apr 02 2020 | 8 years fee payment window open |
Oct 02 2020 | 6 months grace period start (w surcharge) |
Apr 02 2021 | patent expiry (for year 8) |
Apr 02 2023 | 2 years to revive unintentionally abandoned end. (for year 8) |
Apr 02 2024 | 12 years fee payment window open |
Oct 02 2024 | 6 months grace period start (w surcharge) |
Apr 02 2025 | patent expiry (for year 12) |
Apr 02 2027 | 2 years to revive unintentionally abandoned end. (for year 12) |